会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 78. 发明授权
    • Monoclonal antibody-based immunoassay for cyclic DNA adducts resulting
from exposure to crotonaldehyde or acrolein
    • 用于通过暴露于巴豆醛或丙烯醛引起的环状DNA加合物的基于单克隆抗体的免疫测定
    • US4923813A
    • 1990-05-08
    • US144490
    • 1988-01-15
    • Stephen S. HechtPeter G. FoilesFung-Lung Chung
    • Stephen S. HechtPeter G. FoilesFung-Lung Chung
    • C12Q1/68G01N33/53
    • C12Q1/6804G01N33/5308Y10S435/948Y10S436/813Y10S436/822Y10S530/809
    • Monoclonal antibodies specific for the 8R,6R- and 8S,6S-stereoisomers of 3-(2-deoxy-.beta.-D-erythropentofuransyl)-5,6,7,8-tetrahydro-8-hydroxy-6-methylpyrimido[1,2-a]purine-10(3H)one were produced. These cyclic 1,N.sup.2 -propanodeoxyguanosines are formed in DNA exposed to crotonaldehyde in vitro. Three of the four antibodies were most specific for one stereoisomer while the fourth was most specific for the other stereoisomer. Fifty % inhibition of binding in an enzyme-linked immunoabsorbent assay could be achieved with 0.2 picomol of either stereoisomer. A high-pressure liquid chromatography-enzyme-linked immunoabsorbent assay using two of these antibodies and capable of detecting 0.5 .mu.mol of 1,N.sup.2 -propanodeoxyguanosine per mol of deoxyguanosine was developed. The method was validated by comparison to results obtained with fluorescence assay.
    • 对3-(2-脱氧-β-D-赤式呋喃基)-5,6,7,8-四氢-8-羟基-6-甲基嘧啶并[1,2-d]嘧啶的8R,6R和8S,6S立体异构体特异性的单克隆抗体, 2-a]嘌呤-10(3H)。 这些环状1,N 2 - 丙酮脱氧鸟苷在体外在巴豆醛暴露的DNA中形成。 四种抗体中的三种对于一种立体异构体最具特异性,而第四种是其他立体异构体最特异的。 可以用0.2皮摩尔的立体异构体实现在酶联免疫吸附测定中50%的结合抑制。 开发了高压液相色谱 - 酶联免疫吸附测定法,其使用这些抗体中的两种并且能够检测每摩尔脱氧鸟苷的0.5微摩尔的1,N 2 - 丙酮脱氧鸟苷。 通过与荧光测定获得的结果进行比较,验证了该方法。
    • 79. 发明授权
    • Monoclonal antibodies specific for lipid-A determinants of gram negative
bacteria
    • 特异于革兰氏阴性菌的脂质A决定簇的单克隆抗体
    • US4918163A
    • 1990-04-17
    • US855878
    • 1986-04-24
    • Lowell S. Young
    • Lowell S. Young
    • C12N15/02A61K38/00A61K39/02C07K14/005C07K14/195C07K14/41C07K16/00C07K16/12C07K19/00C12N5/00C12N5/10C12N15/00C12N15/12C12P21/00C12P21/08C12R1/91G01N33/569G01N33/577
    • G01N33/56916C07K16/1203C07K16/1214A61K38/00C07K2317/77G01N2333/21G01N2400/50Y10S530/809Y10S530/825Y10S530/864
    • The present invention provides novel hybridoma cell lines which produce monoclonal antibodies (MoAbs) that bind epitopes found on lipopolysaccharide most commonly associated with the endotoxin core of gram negative bacteria and exhibit broad cross-reactivity with gram negative bacteria of different genera and effectively neutralize endotoxin. At least one of the MoAbs disclosed (XMMEN-J5D) binds an epitope also found on gram positive bacteria. The hybridomas are produced by fusing an immortal cell, a cell having the ability to replicate indefinitely in myeloma cell culture, and an effector immune cell following immunization of the immune cell host with a preparation of a gram negative bacteria. While several individual hybridoma cell lines producing monoclonal antibodies to lipopolysaccharide are described, the present invention adds to the state of the art an entire family of hybridoma producing monoclonal antibodies to lipopolysaccharide-associated epitopes.The monoclonal antibodies produced by the hybridoma cell lines of the present invention are useful in the detection of bacterial infections, therapy and prophylaxis of bacterial endotoxemia and infection caused by gram negative bacteria.
    • 本发明提供了产生单克隆抗体(MoAb)的新型杂交瘤细胞系,所述单克隆抗体(MoAb)结合了与通常与革兰氏阴性细菌的内毒素核心最相关的脂多糖上发现的表位,并且表现出与不同属的革兰氏阴性细菌的广泛的交叉反应性并有效中和内毒素。 所公开的至少一种MoAb(XMMEN-J5D)结合在革兰氏阳性细菌上也发现的表位。 杂交瘤通过将具有无限期复制骨髓瘤细胞培养物的能力的永生细胞,具有革兰氏阴性细菌制剂免疫免疫细胞宿主的效应免疫细胞融合而产生。 虽然描述了产生针对脂多糖的单克隆抗体的几种单独的杂交瘤细胞系,但是本发明使得产生针对脂多糖相关表位的单克隆抗体的全部杂交瘤家族成为现有技术。 由本发明的杂交瘤细胞系产生的单克隆抗体可用于细菌感染的检测,治疗和预防细菌内毒素血症和由革兰氏阴性细菌引起的感染。